Skip to main content
. 2021 Jul 24;147(11):3313–3324. doi: 10.1007/s00432-021-03745-w

Table 3.

Cytoplasmic and nuclear HMGA2 expression in malignant and non-malignant ducts

(a) Cytoplasm Nuclei
n % n %
Positive tumor cells
 0% 14 13.2 2 1.9
 < 10% 0 0.0 2 1.9
 11—50% 8 7.5 21 19.8
 51—80% 22 20.8 22 20.8
 > 80% 62 58.5 59 55.7
Staining intensity
 Negative 14 13.2 2 1.9
 Weakly positive 88 83.0 42 39.6
 Moderately positive 4 3.8 35 33.0
 Strongly positive > 80% 0 0.0 27 25.5
Sum score
 0 14 13.2 2 1.9
 2 0 0.0 1 0.9
 3–4 30 28.3 25 23.6
 5–6 62 58.5 57 53.7
 7 0 0.0 21 19.8
(b) Cytoplasm Nuclei
Tumor Non-malignant Tumor Non-malignant
Staining intensity n % n % n % n %
Negative 5 17.9 8 28.6 1 3.6 5 17.9
Weakly positive 23 82.1 18 64.3 13 46.4 14 50.0
Moderately positive 0 0.0 2 7.1 7 25.0 9 32.1
Strongly positive 0 0.0 0 0.0 7 25.0 0 0.0
Staining pattern: tumor vs. non-malignant

No difference

ns, p = 0.5

**

p = 0.003

(a) number of positive cells, staining intensity and corresponding sum score are shown for cytoplasm and nucleus separately. Additionally, particular staining intensity in relation to histologic specification (tumor vs. peritumoral non-malignant) and for cytoplasmic vs. nuclear staining are provided in (b)